Buprenorphine Opioid Treatment During the COVID-19 Pandemic
Open Access
- 12 April 2021
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 181 (8), 1135
- https://doi.org/10.1001/jamainternmed.2021.0777
Abstract
To the Editor To our knowledge, Nguyen et al were the first group to report on the consequences of enabling telehealth initiation of buprenorphine for managemenKeywords
This publication has 3 references indexed in Scilit:
- Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 PandemicJAMA Internal Medicine, 2021
- Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological modelAddiction Science & Clinical Practice, 2021
- COVID-19-related treatment service disruptions among people with single- and polysubstance use concernsJournal of Substance Abuse Treatment, 2020